We are live on ! Find out more
NFC

Northeast Financial Consultants Portfolio holdings

AUM $2.45B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+7.27%
1 Year Est. Return
+15.14%
3 Year Est. Return
+63.77%
5 Year Est. Return
+108.46%
10 Year Est. Return
+198.58%
AUM
$1.63B
AUM Growth
+$66.1M
Cap. Flow
-$38.5M
Cap. Flow %
-2.37%
Top 10 Hldgs %
51.31%
Holding
333
New
16
Increased
61
Reduced
70
Closed
45

Top Buys

Rank Stock Value
1
FMC icon
FMC
FMC
+$8.85M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.52M
3
RC
Ready Capital
RC
+$3.66M
4
BXSL icon
Blackstone Secured Lending
BXSL
+$3.14M
5
PNC icon
PNC Financial Services
PNC
+$3.06M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$13.1M
2
META icon
Meta Platforms (Facebook)
META
+$8.88M
3
AMZN icon
Amazon
AMZN
+$7.4M
4
BRMK
Broadmark Realty Capital Inc. Common Stock
BRMK
+$3.45M
5
SLY
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
+$2.81M

Sector Composition

Rank Sector Weight
1 Healthcare 9.37%
2 Technology 9.07%
3 Financials 8.47%
4 Communication Services 3.99%
5 Consumer Discretionary 3.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LBTYK icon
276
Liberty Global Class C
LBTYK
$3.4B
$185K 0.01%
10,386
– –
PETS icon
277
PetMed Express
PETS
$42.3M
$138K 0.01%
10,000
– –
HTZWW
278
Hertz Global Holdings Warrants
HTZWW
$102M
$119K 0.01%
11,800
-1,500
-11% -$13.6K
RLYB icon
279
Rallybio
RLYB
$87M
$103K 0.01%
2,269
+636
+39% +$31.2K
MYN icon
280
BlackRock MuniYield New York Quality Fund
MYN
$376M
$101K 0.01%
10,000
– –
CLSD
281
DELISTED
Clearside Biomedical
CLSD
$93K 0.01%
5,533
– –
AKLI
282
DELISTED
Akili Inc
AKLI
$62.8K ﹤0.01%
56,554
– –
MGNX icon
283
MacroGenics
MGNX
$249M
$53.5K ﹤0.01%
10,000
– –
CGTX icon
284
Cognition Therapeutics
CGTX
$97M
$44.8K ﹤0.01%
24,500
– –
VERU icon
285
Veru
VERU
$47.6M
$19.3K ﹤0.01%
1,621
– –
ETWO.WS
286
DELISTED
E2open Parent Holdings, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
ETWO.WS
$16.2K ﹤0.01%
30,000
+600
+2% +$336
KRRO icon
287
Korro Bio
KRRO
$196M
$14.8K ﹤0.01%
857
-60
-7% -$1.16K
SPPI
288
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$9.6K ﹤0.01%
10,000
– –
AA icon
289
Alcoa
AA
$14.3B
– –
-11,020
Closed -$469K
ABNB icon
290
Airbnb
ABNB
$111B
– –
-3,180
Closed -$396K
ADSK icon
291
Autodesk
ADSK
$53.1B
– –
-5,615
Closed -$1.17M
APA icon
292
APA Corp
APA
$14.2B
– –
-5,783
Closed -$209K
BHP icon
293
BHP
BHP
$229B
– –
-6,892
Closed -$437K
BIIB icon
294
Biogen
BIIB
$30.1B
– –
-3,039
Closed -$845K
CB icon
295
Chubb
CB
$134B
– –
-1,555
Closed -$302K
CF icon
296
CF Industries
CF
$17.8B
– –
-5,174
Closed -$375K
CMCSA icon
297
Comcast
CMCSA
$91B
– –
-34,789
Closed -$1.32M
CP icon
298
Canadian Pacific Kansas City
CP
$80.8B
– –
-5,000
Closed -$385K
CRL icon
299
Charles River Laboratories
CRL
$13.5B
– –
-2,073
Closed -$418K
DEO icon
300
Diageo
DEO
$52.8B
– –
-3,334
Closed -$604K
10 11
12
13 14

Similar funds

MC
Martin Currie Edinburgh, United Kingdom $2.61B AUM 29.41% 1-Year Est. Return
WBA
Walgreens Boots Alliance Deerfield, Illinois $2.24B AUM 36.34% 1-Year Est. Return
MD
Money Design Tokyo, Japan $2.14B AUM 10.33% 1-Year Est. Return
GL
Graypoint LLC Albany, New York $1.78B AUM 16.72% 1-Year Est. Return
SVCF
Silicon Valley Community Foundation Mountain View, California $1.77B AUM 13% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
MME
Meag Munich Ergo Munich, Germany $3.54B AUM 20% 1-Year Est. Return

Northeast Financial Consultants's Q2 2023 Portfolio in Review

As of Q2 2023, Northeast Financial Consultants held 333 positions worth $1.63B, up 4.2% from $1.56B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Northeast Financial Consultants's Q2 2023 filing shows 16 new, 61 increased, 70 reduced and 45 closed positions. Its largest new stake was FMC: 78,762 shares worth $8.22M. The largest sale was Eli Lilly, an estimated $13.1M.

By sector, the portfolio is most concentrated in Healthcare at 9.4% of assets, down from 11% a quarter earlier, followed by Technology and Financials.

  • Northeast Financial Consultants's largest Q2 2023 buy was FMC: 78,762 shares worth $8.22M.
  • Northeast Financial Consultants added most to Vanguard S&P 500 ETF in Q2 2023, an estimated $4.52M increase.
  • Northeast Financial Consultants's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $13.1M.
  • Northeast Financial Consultants fully exited Broadmark Realty Capital Inc. Common Stock in Q2 2023, selling an estimated $3.45M.
  • Northeast Financial Consultants's ten largest holdings make up 51% of its $1.63B portfolio in Q2 2023.
  • Northeast Financial Consultants opened 16 new positions and closed 45 in Q2 2023.
  • Northeast Financial Consultants's portfolio value rose 4.2% quarter-over-quarter to $1.63B.

Based on Northeast Financial Consultants's 13F filing for Q2 2023, filed 8 Aug 2023.